LORILEE SEBESTA: Open Payments
NPI 1811497407 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$638 in 40 payments from 9 companies in 2025. Trend: 2023 $1,236 · 2024 $539 · 2025 $638
Food & beverage: $638
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 19 | $251 |
| Abbott Laboratories | 8 | $144 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $60 |
| Collegium Pharmaceutical, Inc. | 2 | $43 |
| Medtronic, Inc. | 2 | $41 |
| ABBVIE INC. | 2 | $37 |
| DePuy Synthes Sales Inc. | 1 | $32 |
| Valinor Pharma, LLC | 1 | $20 |
| SPR Therapeutics, Inc | 1 | $11 |
Products named: RELISTOR, ETERNA, JOURNAVX, Belbuca, QULIPTA, ORTHOVISC, KYPHON EXPRESS II KYPHOPAK TRAY, MOVANTIK.
Industry payments across MO — which companies pay providers there.
